ATCO LTD -CLASS I (ACO-X.CA) Fundamental Analysis & Valuation

TSX:ACO-X • CA0467894006

Current stock price

68.88 CAD
+0.92 (+1.35%)
Last:

This ACO-X.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ACO-X.CA Profitability Analysis

1.1 Basic Checks

  • ACO-X had positive earnings in the past year.
  • ACO-X had a positive operating cash flow in the past year.
  • Each year in the past 5 years ACO-X has been profitable.
  • In the past 5 years ACO-X always reported a positive cash flow from operatings.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.54%, ACO-X is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
  • The Return On Equity of ACO-X (3.32%) is comparable to the rest of the industry.
  • The Return On Invested Capital of ACO-X (1.94%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACO-X is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA 0.54%
ROE 3.32%
ROIC 1.94%
ROA(3y)1.28%
ROA(5y)1.29%
ROE(3y)7.46%
ROE(5y)7.36%
ROIC(3y)3.06%
ROIC(5y)3.31%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • ACO-X has a better Profit Margin (2.92%) than 73.68% of its industry peers.
  • In the last couple of years the Profit Margin of ACO-X has declined.
  • ACO-X has a Operating Margin of 13.26%. This is amonst the worse of the industry: ACO-X underperforms 89.47% of its industry peers.
  • ACO-X's Operating Margin has declined in the last couple of years.
  • ACO-X has a Gross Margin (74.80%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of ACO-X has remained more or less at the same level.
Industry RankSector Rank
OM 13.26%
PM (TTM) 2.92%
GM 74.8%
OM growth 3Y-18.45%
OM growth 5Y-12.68%
PM growth 3Y-26.79%
PM growth 5Y-14.52%
GM growth 3Y-1.23%
GM growth 5Y-1.11%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

5

2. ACO-X.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACO-X is destroying value.
  • ACO-X has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ACO-X has less shares outstanding
  • The debt/assets ratio for ACO-X is higher compared to a year ago.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 0.72, we must say that ACO-X is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ACO-X (0.72) is better than 84.21% of its industry peers.
  • The Debt to FCF ratio of ACO-X is 20.55, which is on the high side as it means it would take ACO-X, 20.55 years of fcf income to pay off all of its debts.
  • ACO-X's Debt to FCF ratio of 20.55 is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
  • ACO-X has a Debt/Equity ratio of 2.84. This is a high value indicating a heavy dependency on external financing.
  • ACO-X has a worse Debt to Equity ratio (2.84) than 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.84
Debt/FCF 20.55
Altman-Z 0.72
ROIC/WACC0.39
WACC4.94%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.80 indicates that ACO-X should not have too much problems paying its short term obligations.
  • The Current ratio of ACO-X (1.80) is better than 100.00% of its industry peers.
  • A Quick Ratio of 1.70 indicates that ACO-X should not have too much problems paying its short term obligations.
  • The Quick ratio of ACO-X (1.70) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.7
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. ACO-X.CA Growth Analysis

3.1 Past

  • ACO-X shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.46%.
  • Measured over the past years, ACO-X shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.40% on average per year.
  • Looking at the last year, ACO-X shows a small growth in Revenue. The Revenue has grown by 4.07% in the last year.
  • The Revenue has been growing slightly by 5.45% on average over the past years.
EPS 1Y (TTM)7.46%
EPS 3Y7.51%
EPS 5Y8.4%
EPS Q2Q%5.38%
Revenue 1Y (TTM)4.07%
Revenue growth 3Y1.09%
Revenue growth 5Y5.45%
Sales Q2Q%0%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.70% on average over the next years.
  • The Revenue is expected to grow by 6.30% on average over the next years.
EPS Next Y5.05%
EPS Next 2Y4.5%
EPS Next 3Y4.7%
EPS Next 5YN/A
Revenue Next Year4.03%
Revenue Next 2Y6.76%
Revenue Next 3Y6.3%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

3

4. ACO-X.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.94 indicates a correct valuation of ACO-X.
  • 89.47% of the companies in the same industry are more expensive than ACO-X, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, ACO-X is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 14.22 indicates a correct valuation of ACO-X.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ACO-X.
  • ACO-X's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 14.94
Fwd PE 14.22
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ACO-X's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ACO-X is more expensive than 63.16% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACO-X is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 10.79
EV/EBITDA 8.8
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACO-X does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.96
PEG (5Y)1.78
EPS Next 2Y4.5%
EPS Next 3Y4.7%

5

5. ACO-X.CA Dividend Analysis

5.1 Amount

  • ACO-X has a Yearly Dividend Yield of 3.05%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 4.27, ACO-X's dividend is way lower than its industry peers. On top of this 94.74% of the companies listed in the same industry pay a better dividend than ACO-X!
  • Compared to an average S&P500 Dividend Yield of 1.90, ACO-X pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.05%

5.2 History

  • The dividend of ACO-X has a limited annual growth rate of 3.05%.
  • ACO-X has paid a dividend for at least 10 years, which is a reliable track record.
  • ACO-X has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.05%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • ACO-X pays out 151.33% of its income as dividend. This is not a sustainable payout ratio.
  • ACO-X's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP151.33%
EPS Next 2Y4.5%
EPS Next 3Y4.7%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ACO-X.CA Fundamentals: All Metrics, Ratios and Statistics

ATCO LTD -CLASS I

TSX:ACO-X (4/2/2026, 7:00:00 PM)

68.88

+0.92 (+1.35%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)02-26
Earnings (Next)04-23
Inst Owners27.89%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap6.95B
Revenue(TTM)5.14B
Net Income(TTM)150.00M
Analysts78.67
Price Target68.78 (-0.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.05%
Yearly Dividend2.02
Dividend Growth(5Y)3.05%
DP151.33%
Div Incr Years31
Div Non Decr Years34
Ex-Date02-26
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)4.05%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.45%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)3.85%
EPS beat(12)10
Avg EPS beat(12)4.12%
EPS beat(16)13
Avg EPS beat(16)4.33%
Revenue beat(2)0
Avg Revenue beat(2)-11.28%
Min Revenue beat(2)-20.57%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-10.24%
Min Revenue beat(4)-20.57%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.21%
Revenue beat(12)0
Avg Revenue beat(12)-11.97%
Revenue beat(16)1
Avg Revenue beat(16)-9.88%
PT rev (1m)11.58%
PT rev (3m)11.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.73%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.15%
Revenue NY rev (3m)6.06%
Valuation
Industry RankSector Rank
PE 14.94
Fwd PE 14.22
P/S 1.35
P/FCF 10.79
P/OCF 2.8
P/B 1.54
P/tB 2.1
EV/EBITDA 8.8
EPS(TTM)4.61
EY6.69%
EPS(NY)4.84
Fwd EY7.03%
FCF(TTM)6.39
FCFY9.27%
OCF(TTM)24.63
OCFY35.76%
SpS50.99
BVpS44.83
TBVpS32.76
PEG (NY)2.96
PEG (5Y)1.78
Graham Number68.19
Profitability
Industry RankSector Rank
ROA 0.54%
ROE 3.32%
ROCE 2.6%
ROIC 1.94%
ROICexc 2.04%
ROICexgc 2.15%
OM 13.26%
PM (TTM) 2.92%
GM 74.8%
FCFM 12.52%
ROA(3y)1.28%
ROA(5y)1.29%
ROE(3y)7.46%
ROE(5y)7.36%
ROIC(3y)3.06%
ROIC(5y)3.31%
ROICexc(3y)3.16%
ROICexc(5y)3.44%
ROICexgc(3y)3.34%
ROICexgc(5y)3.61%
ROCE(3y)4.12%
ROCE(5y)4.45%
ROICexgc growth 3Y-21.26%
ROICexgc growth 5Y-11.62%
ROICexc growth 3Y-21.39%
ROICexc growth 5Y-11.81%
OM growth 3Y-18.45%
OM growth 5Y-12.68%
PM growth 3Y-26.79%
PM growth 5Y-14.52%
GM growth 3Y-1.23%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.84
Debt/FCF 20.55
Debt/EBITDA 6.12
Cap/Depr 130.22%
Cap/Sales 35.78%
Interest Coverage 1.23
Cash Conversion 118.57%
Profit Quality 429.33%
Current Ratio 1.8
Quick Ratio 1.7
Altman-Z 0.72
F-Score6
WACC4.94%
ROIC/WACC0.39
Cap/Depr(3y)181.88%
Cap/Depr(5y)190.83%
Cap/Sales(3y)35.1%
Cap/Sales(5y)33.69%
Profit Quality(3y)204.44%
Profit Quality(5y)208.72%
High Growth Momentum
Growth
EPS 1Y (TTM)7.46%
EPS 3Y7.51%
EPS 5Y8.4%
EPS Q2Q%5.38%
EPS Next Y5.05%
EPS Next 2Y4.5%
EPS Next 3Y4.7%
EPS Next 5YN/A
Revenue 1Y (TTM)4.07%
Revenue growth 3Y1.09%
Revenue growth 5Y5.45%
Sales Q2Q%0%
Revenue Next Year4.03%
Revenue Next 2Y6.76%
Revenue Next 3Y6.3%
Revenue Next 5YN/A
EBIT growth 1Y-43.21%
EBIT growth 3Y-17.55%
EBIT growth 5Y-7.91%
EBIT Next Year436.59%
EBIT Next 3Y84.23%
EBIT Next 5YN/A
FCF growth 1Y63.87%
FCF growth 3Y-7.47%
FCF growth 5Y-4.6%
OCF growth 1Y13.06%
OCF growth 3Y1.21%
OCF growth 5Y6.15%

ATCO LTD -CLASS I / ACO-X.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ACO-X.CA.


What is the valuation status of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a valuation rating of 3 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Overvalued.


Can you provide the profitability details for ATCO LTD -CLASS I?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ATCO LTD -CLASS I (ACO-X.CA) stock?

The Price/Earnings (PE) ratio for ATCO LTD -CLASS I (ACO-X.CA) is 14.94 and the Price/Book (PB) ratio is 1.54.


How sustainable is the dividend of ATCO LTD -CLASS I (ACO-X.CA) stock?

The dividend rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10 and the dividend payout ratio is 151.33%.